South Sudan launches new R21 Malaria vaccine to protect children

South Sudan has initiated a nationwide campaign to administer the R21 malaria vaccine, aiming to vaccinate more than 265,897 children aged five to 18 months with four doses. The campaign will focus on 28 counties across six states heavily affected by the malaria epidemic.

Health Minister Yolanda Awel Deng emphasised South Sudan's commitment to improving children's health outcomes by reducing the impact of malaria. Deng noted that this roll-out is part of a broader strategy to combat the disease and enhance public health.

"The continued use of this vaccine, alongside preventive measures such as insecticide-treated bed nets and timely access to medical care, will be instrumental in our efforts to eliminate malaria in South Sudan," Deng said.

The minister received the first consignment of 645,000 vaccines with the help of the World Health Organization (WHO) alongside other stakeholders.

Humphrey Karamagi, a South Sudan WHO representative, stated that the organization has despatched experts to assist with distribution and assure the vaccine's effective implementation.

"The rollout of the malaria vaccine is a game-changer in our fight against this deadly disease. With the support of our partners, we are committed to protecting young children and reducing the malaria burden in the country," Karamagi revealed.

Malaria is the leading cause of illness and death especially in young children in South Sudan. In 2022, the country recorded 6,680 deaths out of an estimated 2.8 million malaria cases. With approximately 7,630 new cases and 18 fatalities daily, South Sudan is one of the countries with the highest malaria incidence rate in the region.

WHO Africa Regional Director Dr Matshidiso Moeti has lauded South Sudan's move terming it a crucial step in saving thousands of lives at great risk of the disease.

South Sudan becomes the second country after Cote d'Ivoire to deploy the R21 vaccine.